InnoPharma

InnoPharma Develops Niche Generic Drugs, Specialty Pharmaceuticals, and Biopharmaceutical ProductsInnoPharma develops niche generic drugs, specialty pharmaceuticals, and biopharmaceutical products. The company has built up expertise in the development of complex injectable products, including injection pens and sustained-release injectables. It is currently working on expanding this expertise to new dosage forms such as oral suspensions and nasal sprays. InnoPharma’s current product portfolio includes 10 generic drugs approved by the U.S. Food and Drug Administration (FDA), 19 products with applications submitted to the FDA, and over 30 injectable and ophthalmic products under development. The company focuses on developing novel formulations of existing drugs, including various products that are challenging to manufacture, such as those requiring complex production capabilities or presenting challenges in terms of bioequivalence, particularly in areas like cancer and central nervous system disorders.